<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Biogen Idec,2003,2005,2006,2007,As of 2004,Australia,Austria,Autoimmune disorders,Avonex,Benelux" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Biogen Idec - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Biogen Idec</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <table class="infobox" style="width:23em; font-size:90%;">
<tr>
<td colspan="2" style="text-align: center; font-size:larger;"><b>Biogen Idec, Inc.</b></td>
</tr>
<tr>
<td colspan="2" style="text-align:center; padding:16px 0 16px 0;"><a href="../../../b/i/o/Image%7EBiogen_Idec_logo.gif_86d1.html" class="image" title="Image:Biogen_Idec_logo.gif"><img src="../../../upload/c/c6/Biogen_Idec_logo.gif" alt="Image:Biogen_Idec_logo.gif" width="220" height="97" longdesc="../../../b/i/o/Image%7EBiogen_Idec_logo.gif_86d1.html" /></a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../t/y/p/Category%7ETypes_of_companies_064c.html" title="Category:Types of companies">Type</a></th>
<td><a href="../../../p/u/b/Public_company.html" title="Public company">Public</a> (<a href="../../../n/a/s/NASDAQ_7dfd.html" title="NASDAQ">NASDAQ</a>: <a href="http://quotes.nasdaq.com/asp/SummaryQuote.asp?symbol=BIIB&amp;selected=BIIB" class="external text" title="http://quotes.nasdaq.com/asp/SummaryQuote.asp?symbol=BIIB&amp;selected=BIIB" rel="nofollow">BIIB</a>)</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;">Founded</th>
<td><a href="../../../2/0/0/2003.html" title="2003">2003</a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;">Headquarters</th>
<td><a href="../../../c/a/m/Cambridge%2C_Massachusetts_da41.html" title="Cambridge, Massachusetts">Cambridge, Massachusetts</a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;">Key&#160;people</th>
<td>Jim Mullen, CEO</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../i/n/d/Industry.html" title="Industry">Industry</a></th>
<td><a href="../../../b/i/o/Biotechnology.html" title="Biotechnology">Biotechnology</a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../p/r/o/Product_%28business%29.html" title="Product (business)">Products</a></th>
<td><a href="../../../r/i/t/Rituxan.html" title="Rituxan">Rituxan</a>, <a href="../../../z/e/v/Zevalin.html" title="Zevalin">Zevalin</a>, <a href="../../../a/v/o/Avonex.html" title="Avonex">Avonex</a>, <a href="../../../t/y/s/Tysabri.html" title="Tysabri">Tysabri</a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../r/e/v/Revenue.html" title="Revenue">Revenue</a></th>
<td>2.26 billion <a href="../../../u/s/d/USD_3518.html" title="USD">USD</a></td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../e/m/p/Employment.html" title="Employment">Employees</a></th>
<td>4,166</td>
</tr>
<tr>
<th style="text-align:right; padding-right:0.75em;"><a href="../../../w/e/b/Website.html" title="Website">Website</a></th>
<td><a href="http://www.biogenidec.com" class="external free" title="http://www.biogenidec.com" rel="nofollow">http://www.biogenidec.com</a></td>
</tr>
</table>
<p><b>Biogen Idec, Inc.</b> (<a href="../../../n/a/s/NASDAQ_7dfd.html" title="NASDAQ">NASDAQ</a>: <a href="http://quotes.nasdaq.com/asp/SummaryQuote.asp?symbol=BIIB&amp;selected=BIIB" class="external text" title="http://quotes.nasdaq.com/asp/SummaryQuote.asp?symbol=BIIB&amp;selected=BIIB" rel="nofollow">BIIB</a>) is a <a href="../../../b/i/o/Biotechnology.html" title="Biotechnology">biotechnology</a> company specializing in drugs for <a href="../../../n/e/u/Neurology.html" title="Neurology">neurology</a>, <a href="../../../a/u/t/Autoimmune_disorders.html" title="Autoimmune disorders">autoimmune disorders</a> and <a href="../../../c/a/n/Cancer.html" title="Cancer">cancer</a>. The company was formed in <a href="../../../2/0/0/2003.html" title="2003">2003</a> by the <a href="../../../m/e/r/Merger.html" title="Merger">merger</a> of <a href="../../../c/a/m/Cambridge%2C_Massachusetts_da41.html" title="Cambridge, Massachusetts">Cambridge, Massachusetts</a>-based Biogen and <a href="../../../s/a/n/San_Diego%2C_California_4c0a.html" title="San Diego, California">San Diego, California</a>-based Idec Pharmaceuticals.</p>
<p>Biogen Idec is a member of the <a href="../../../s/%26/p/S%26P_500_49e4.html" title="S&amp;P 500">S&amp;P 500</a>, <a href="../../../s/%26/p/S%26P_1500_9672.html" title="S&amp;P 1500">S&amp;P 1500</a>, and <a href="../../../n/a/s/NASDAQ-100_43e5.html" title="NASDAQ-100">NASDAQ-100</a>. It employs a little over 4,000 employees.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Locations_of_operation"><span class="tocnumber">1</span> <span class="toctext">Locations of operation</span></a></li>
<li class="toclevel-1"><a href="#Competitors"><span class="tocnumber">2</span> <span class="toctext">Competitors</span></a></li>
<li class="toclevel-1"><a href="#Management"><span class="tocnumber">3</span> <span class="toctext">Management</span></a></li>
<li class="toclevel-1"><a href="#News"><span class="tocnumber">4</span> <span class="toctext">News</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Locations_of_operation" id="Locations_of_operation"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biogen_Idec_b97a.html" title="Edit section: Locations of operation">edit</a>]</span> <span class="mw-headline">Locations of operation</span></h2>
<p>Biogen Idec is headquartered in <a href="../../../k/e/n/Kendall_Square_20b0.html" title="Kendall Square">Kendall Square</a> in Cambridge, Massachusetts, and operates <a href="../../../r/e/s/Research_and_development.html" title="Research and development">research and development</a> facilities in Cambridge and San Diego. Biogen Idec operates manufacturing facilities in <a href="../../../k/e/n/Kendall_Square_20b0.html" title="Kendall Square">Kendall Square</a>, in <a href="../../../r/e/s/Research_Triangle_Park%2C_North_Carolina_4c6d.html" title="Research Triangle Park, North Carolina">Research Triangle Park, North Carolina</a>, and Hoofddorp, Netherlands. The company is also building a Large Scale Manufacturing plant in Hillerod, Denmark, which is expected to go online in 2008.</p>
<p>Biogen Idec maintains its international headquarters in <a href="../../../z/u/g/Zug.html" title="Zug">Zug</a>, <a href="../../../s/w/i/Switzerland.html" title="Switzerland">Switzerland</a>, and operates an International regulatory &amp; clinical center of excellence in Maidenhead, UK. In Europe, Biogen Idec has direct commercial affiliates in <a href="../../../g/e/r/Germany.html" title="Germany">Germany</a>, <a href="../../../f/r/a/France.html" title="France">France</a>, <a href="../../../s/p/a/Spain.html" title="Spain">Spain</a>/<a href="../../../p/o/r/Portugal.html" title="Portugal">Portugal</a>, <a href="../../../u/n/i/United_Kingdom_5ad7.html" title="United Kingdom">UK</a>/<a href="../../../i/r/e/Ireland.html" title="Ireland">Ireland</a>, the <a href="../../../b/e/n/Benelux.html" title="Benelux">Benelux</a>, <a href="../../../s/w/e/Sweden.html" title="Sweden">Sweden</a>, <a href="../../../d/e/n/Denmark.html" title="Denmark">Denmark</a>, <a href="../../../n/o/r/Norway.html" title="Norway">Norway</a>, <a href="../../../f/i/n/Finland.html" title="Finland">Finland</a>, and <a href="../../../a/u/s/Austria.html" title="Austria">Austria</a>. In <a href="../../../i/t/a/Italy.html" title="Italy">Italy</a> and in <a href="../../../s/w/i/Switzerland.html" title="Switzerland">Switzerland</a>, Biogen Idec markets its products through two joint venture companies set up with the privately held Italian company Dompe Biotec. Biogen Idec also has offices in <a href="../../../c/a/n/Canada.html" title="Canada">Canada</a>, <a href="../../../a/u/s/Australia.html" title="Australia">Australia</a>, and <a href="../../../j/a/p/Japan.html" title="Japan">Japan</a>.</p>
<p><a name="Competitors" id="Competitors"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biogen_Idec_b97a.html" title="Edit section: Competitors">edit</a>]</span> <span class="mw-headline">Competitors</span></h2>
<p>Biogen Idec's principal competitors include <a href="../../../t/e/v/Teva_Pharmaceutical_Industries%2C_Ltd._14e9.html" title="Teva Pharmaceutical Industries, Ltd.">Teva</a>, <a href="../../../s/e/r/Serono.html" title="Serono">Serono</a>, and <a href="../../../s/c/h/Schering_AG_a1bb.html" title="Schering AG">Schering AG</a>/<a href="../../../b/e/r/Berlex.html" title="Berlex">Berlex</a>.</p>
<p><a href="../../../a/s/_/As_of_2004.html" title="As of 2004">As of 2004</a>, Biogen Idec derives most of its income from sales of <a href="../../../m/u/l/Multiple_sclerosis.html" title="Multiple sclerosis">multiple sclerosis</a> treatment <a href="../../../i/n/t/Interferon_beta-1a.html" title="Interferon beta-1a">Avonex</a> and from partnership royalties on Rituxan from <a href="../../../g/e/n/Genentech.html" title="Genentech">Genentech</a>, which markets <a href="../../../r/i/t/Rituximab.html" title="Rituximab">Rituxan</a> in the US. Roche markets Rituxan outside the US as MabThera.</p>
<p><a name="Management" id="Management"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biogen_Idec_b97a.html" title="Edit section: Management">edit</a>]</span> <span class="mw-headline">Management</span></h2>
<p>BIIB is managed day-to-day by an executive group composed of nine officers. As customary for a publicly-traded company, BIIB is also overseen by a board of directors that votes on important company decisions. The executive chairman and chief executive officer both hold positions on the board of directors.</p>
<p><b>Chairman of the Board:</b> Bruce R. Ross<br />
<b>President, Chief Executive Officer:</b> <a href="http://www.investor.reuters.wallst.com/stocks/OfficerProfile.asp?rpc=66&amp;symbol=BIIB.O&amp;ID=425984" class="external text" title="http://www.investor.reuters.wallst.com/stocks/OfficerProfile.asp?rpc=66&amp;symbol=BIIB.O&amp;ID=425984" rel="nofollow">James C. Mullen</a><br />
<b>President, Research and Development:</b> Cecil B. Pickett<br />
<b>Executive Vice President, Development:</b> Burt A. Adelman<br />
<b>Executive Vice President, New Ventures:</b> John M. Dunn<br />
<b>Executive Vice President, Finance and Chief Financial Officer:</b> Peter N. Kellogg<br />
<b>Executive Vice President, Corporate Strategy and Communication:</b> Connie L. Matsui<br />
<b>Executive Vice President, Human Resources:</b> Craig Eric Schneier, Ph.D.<br />
<b>Executive Vice President, Business Development:</b> Mark Wiggins<br />
<b>Secretary (entry level):</b> Molly Roundabush<br />
<b>Scientist:</b> Michael Calcagno<br />
<b>Directors:</b> Alan Belzer, Lawrence C. Best, Alan B. Glassberg, Mary L. Good, Thomas F. Keller, Robert W. Pangia, Bruce R. Ross, The Honorable Lynn Schenk, Phillip A. Sharp, Willian D. Young</p>
<p><a name="News" id="News"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biogen_Idec_b97a.html" title="Edit section: News">edit</a>]</span> <span class="mw-headline">News</span></h2>
<p>On <a href="../../../j/a/n/January_24.html" title="January 24">January 24</a>, <a href="../../../2/0/0/2007.html" title="2007">2007</a>, Biogen Idec announced a planned construction project at their San Diego site, estimated to cost on the order of $1,000,000. The construction will consist of a magnificent "walkway in the sky" joining one of the laboratory buildings with the executive offices. "Such an undertaking will be the first of its kind in the Biotech industry. Once again, Biogen Idec is leading the pack in innovation," stated a noticeably giddy CEO James Mullen. "Some people say that a million dollars is a lot of money for a pipe dream," Mullen continued, "but seriously folks, that's less than a third of my annual bonus-- chump change!"</p>
<p>On <a href="../../../m/a/r/March_29.html" title="March 29">March 29</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>, Biogen Idec and Elan announced that they had re-initiated clinical dosing of TYSABRI monotherapy in a safety extension study program in multiple sclerosis (MS). Patients who previously participated in the Phase III MS trials and subsequent safety evaluation are eligible to be screened for entry in this open label multi-center study.</p>
<p>On <a href="../../../m/a/r/March_8.html" title="March 8">March 8</a>, <a href="../../../2/0/0/2006.html" title="2006">2006</a>, the Peripheral and Central Nervous System Drugs Advisory Committee of the FDA voted unanimously to recommend reintroduction of TYSABRI as a treatment for relapsing forms of MS.</p>
<p>On <a href="../../../f/e/b/February_28.html" title="February 28">February 28</a>, <a href="../../../2/0/0/2005.html" title="2005">2005</a>, Biogen Idec and marketing partner <a href="../../../e/l/%C3%A1/El%C3%A1n.html" title="Elán">Elan Pharmaceuticals</a> voluntarily suspended marketing of their product TYSABRI (natalizumab), and also suspended dosing in all ongoing clinical trials. TYSABRI had been approved in the US in November 2004 for treatment of patients with relapsing remitting <a href="../../../m/u/l/Multiple_sclerosis.html" title="Multiple sclerosis">multiple sclerosis</a> (MS).</p>
<p>The two companies announced the suspension after two participants involved in one study were diagnosed with a severe brain condition, progressive multifocal leukoencephalopathy (<a href="../../../p/m/l/PML_73fb.html" title="PML">PML</a>), after two years of combination therapy with AVONEX, another Biogen Idec product. One of those two patients died. Subsequently, another patient who had previously died in a separate clinical trial of TYSABRI in patients with <a href="../../../c/r/o/Crohns_Disease_99a7.html" title="Crohns Disease">Crohns Disease</a> was re-evaluated as having had PML. In total, 3 cases of PML were identified, of which 2 cases were fatal.</p>
<p>Biogen Idec stock lost more than 40% of its value when the drug suspension news was released on February 28, 2005.</p>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../b/i/o/Biogen_Idec_b97a.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.biogen.com/" class="external text" title="http://www.biogen.com/" rel="nofollow">Biogen IDEC - Home</a></li>
<li><a href="http://biz.yahoo.com/ic/13/13209.html" class="external text" title="http://biz.yahoo.com/ic/13/13209.html" rel="nofollow">Yahoo! - Biogen Idec Inc. Company Profile</a></li>
<li><a href="http://en.wikinews.org/wiki/Elan%3B_Biogen_withdraw_MS_drug_after_death/" class="external text" title="http://en.wikinews.org/wiki/Elan%3B_Biogen_withdraw_MS_drug_after_death/" rel="nofollow">Tysabri Pulled from the drug market</a></li>
</ul>

<!-- 
Pre-expand include size: 6447 bytes
Post-expand include size: 2503 bytes
Template argument size: 874 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../b/i/o/Biogen_Idec_b97a.html">http://en.wikipedia.org../../../b/i/o/Biogen_Idec_b97a.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_listed_on_NASDAQ_e0fd.html" title="Category:Companies listed on NASDAQ">Companies listed on NASDAQ</a></span> | <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_in_the_NASDAQ_Biotechnology_Index_4b96.html" title="Category:Companies in the NASDAQ Biotechnology Index">Companies in the NASDAQ Biotechnology Index</a></span> | <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_based_in_San_Diego_County_d7b0.html" title="Category:Companies based in San Diego County">Companies based in San Diego County</a></span> | <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_based_in_Massachusetts_ca81.html" title="Category:Companies based in Massachusetts">Companies based in Massachusetts</a></span> | <span dir='ltr'><a href="../../../b/i/o/Category%7EBiotechnology_companies_ac7f.html" title="Category:Biotechnology companies">Biotechnology companies</a></span> | <span dir='ltr'><a href="../../../p/h/a/Category%7EPharmaceutical_companies_7560.html" title="Category:Pharmaceutical companies">Pharmaceutical companies</a></span> | <span dir='ltr'><a href="../../../c/o/m/Category%7ECompanies_established_in_2003_1794.html" title="Category:Companies established in 2003">Companies established in 2003</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../b/i/o/Biogen_Idec_b97a.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../b/i/o/Talk%7EBiogen_Idec_da3b.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Biogen_Idec">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/b/i/o/Biogen_Idec_b97a.html">Deutsch</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 22:39, 25 March 2007 by Wikipedia user <a href="../../../a/m/c/User%7EAmcl_e8c7.html" title="User:Amcl">Amcl</a>. Based on work by Wikipedia user(s) <a href="../../../t/h/e/User%7EThe_wub_6388.html" title="User:The wub">The wub</a>, <a href="../../../g/w/e/User%7EGwernol_c4bf.html" title="User:Gwernol">Gwernol</a>, <a href="../../../p/a/g/User%7EPage_Up_2a2b.html" title="User:Page Up">Page Up</a>, <a href="../../../w/i/l/User%7EWildball_f29b.html" title="User:Wildball">Wildball</a>, <a href="../../../g/r/e/User%7EGreenshed_5a67.html" title="User:Greenshed">Greenshed</a>, Zhengts, <a href="../../../g/e/o/User%7EGeorge_Church_0613.html" title="User:George Church">George Church</a>, Vitasthefetus, <a href="../../../s/o/l/User%7ESolarisworld_e471.html" title="User:Solarisworld">Solarisworld</a>, <a href="../../../l/o/2/User%7ELo2u_7160.html" title="User:Lo2u">Lo2u</a>, <a href="../../../e/v/r/User%7EEvrik_3a44.html" title="User:Evrik">Evrik</a>, <a href="../../../c/a/n/User%7ECan%27t_sleep%2C_clown_will_eat_me_7058.html" title="User:Can't sleep, clown will eat me">Can't sleep, clown will eat me</a>, <a href="../../../1/2/1/User%7E121a0012.html" title="User:121a0012">121a0012</a>, <a href="../../../t/h/e/User%7EThepangelinanpost_f801.html" title="User:Thepangelinanpost">Thepangelinanpost</a>, <a href="../../../d/i/b/User%7EDiberri_3d04.html" title="User:Diberri">Diberri</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../c/a/t/User%7ECatapult_5a86.html" title="User:Catapult">Catapult</a>, <a href="../../../m/a/l/User%7EMalepheasant_b77c.html" title="User:Malepheasant">Malepheasant</a>, <a href="../../../a/n/d/User%7EAndman8_44a5.html" title="User:Andman8">Andman8</a>, <a href="../../../r/o/b/User%7ERobyWayne_5f41.html" title="User:RobyWayne">RobyWayne</a>, <a href="../../../t/e/s/User%7ETestPilot_548e.html" title="User:TestPilot">TestPilot</a>, <a href="../../../f/l/a/User%7EFlaBot_747f.html" title="User:FlaBot">FlaBot</a>, <a href="../../../m/y/s/User%7EMysid_64a6.html" title="User:Mysid">Mysid</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, <a href="../../../e/d/c/User%7EEdcolins_06ae.html" title="User:Edcolins">Edcolins</a>, <a href="../../../d/2E/_/User%7ED._Wu_3a90.html" title="User:D. Wu">D. Wu</a>, Ibpassociation, <a href="../../../p/o/s/User%7EPostdlf_dca8.html" title="User:Postdlf">Postdlf</a>, <a href="../../../c/g/o/User%7ECGorman_73ee.html" title="User:CGorman">CGorman</a>, <a href="../../../j/e/r/User%7EJerryseinfeld_1f0e.html" title="User:Jerryseinfeld">Jerryseinfeld</a>, <a href="../../../h/a/d/User%7EHadal_a4d0.html" title="User:Hadal">Hadal</a>, <a href="../../../k/a/t/User%7EKate_3866.html" title="User:Kate">Kate</a>, <a href="../../../m/e/e/User%7EMeelar_6424.html" title="User:Meelar">Meelar</a> and <a href="../../../d/a/n/User%7EDanKeshet_ba33.html" title="User:DanKeshet">DanKeshet</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
